The production of PD-1 antibodies in SLE may break the immune tolerance established by the PD-L1 expression on epithelial and endothelial cells [117], resulting in nephritis, similar to the cases identified with PD-1 therapies [118]. Here, PDCD1 is linked to systemic lupus erythematosus.